China Law & Practice

Follow us:

profile

China Law & Practice

CLP_editorial

CLP_editorial profile

China sets up circuit courts: http://t.co/0XsyrHBHCG and http://t.co/pO2c4nypUa

Jan 29 2015 10:00 ·  reply ·  retweet ·  favourite
CLP_editorial profile

Forget elephants in rooms, when discussing China's AML there is an anaconda in the chandelier: http://t.co/SgULRVsCHK @donaldcclarke

Jan 29 2015 08:12 ·  reply ·  retweet ·  favourite
CLP_editorial profile

Analysis of draft patent admin enforcement rules: http://t.co/tEQD5rtNQI Cases increased 50% last year. From @cohenschinaipr

Jan 28 2015 02:27 ·  reply ·  retweet ·  favourite

Change font size: Switch to default font size Switch to medium font size Switch to large font size

Patent System to Catch Up with Pharmaceutical Industry Expansion

The pharmaceutical industry in China has been expanding in recent years as the government strives to invent its own drugs and brands. However, the prevalence of counterfeit and generic drugs still remains a significant IP issue. The patent system needs further development before it will be able to properly protect patent holders.

Issue: June 2008

Keywords (click to search): Pharmaceutical drugs counterfeit generic

  The execution of Zheng Xiaoyu for corruption and dereliction of duty made headlines last year. As former director of Chinese watchdog the State Food and Drug Administration (SFDA), Zheng's death sentence reflects the PRC government's determination to protect consumers. For the pharmaceutical industry, the execution represented a step in the right direction. This sector has been widely criticized due to the prevalence of fake drugs and the lack of intellectual property (IP) protection from the government. The 2003 SARS attack, worldwide anger over deaths caused by the exportation of contaminated food and fake drugs, and Zheng's approval of unsafe drugs in violation of new rules all exposed China's lack of enforcement in the health care system. The Zheng scandal alerted the government to the need to reform the nation's pharmaceutical image by promulgating new measures and regulations. At the opening of the National People's Congress Premier Wen Jiabao emphasized the...


Register with China Law & Practice to unlock our premium content for the next 14 days.

**Full text translations are only available for individual purchase or as part of a subscription.
**